Verve Therapeutics is a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. It was incorporated in 2018 and is based in Cambridge, Massachusetts.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Verve Therapeutics news
21.07.2022
Vertex Pharmaceuticals has agreed to an exclusive four-year global research collaboration with Verve Therapeutics to discover and develop an in vivo gene editing program for liver disease. Verve will conduct the preclinical development, and Vertex will provide $60 million in funding and will be responsible for subsequent development, manufacturing and commer...
Source: 
investors.vrtx.com
investors.vrtx.com
General information
| Company name | Verve Therapeutics |
|---|---|
| Tags | #biotechnology, #genome |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | 500 Technology Square Suite 901 Cambridge, MA 02139 United States |
| Mailing address | 500 Technology Square Suite 901 Cambridge, MA 02139 United States |
| Website | ir.vervetx.com |
English (US) 